Zacks: Brokerages Anticipate AngioDynamics, Inc. (ANGO) to Announce $0.16 EPS

Analysts expect that AngioDynamics, Inc. (NASDAQ:ANGO) will report earnings of $0.16 per share for the current quarter, Zacks reports. Three analysts have made estimates for AngioDynamics’ earnings, with the highest EPS estimate coming in at $0.16 and the lowest estimate coming in at $0.15. AngioDynamics reported earnings per share of $0.19 in the same quarter last year, which would indicate a negative year over year growth rate of 15.8%. The company is expected to report its next earnings report on Wednesday, July 12th.

According to Zacks, analysts expect that AngioDynamics will report full year earnings of $0.69 per share for the current fiscal year, with EPS estimates ranging from $0.69 to $0.70. For the next fiscal year, analysts forecast that the company will report earnings of $0.68 per share, with EPS estimates ranging from $0.66 to $0.70. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that cover AngioDynamics.

AngioDynamics (NASDAQ:ANGO) last issued its quarterly earnings data on Thursday, March 30th. The medical instruments supplier reported $0.19 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.15 by $0.04. AngioDynamics had a positive return on equity of 5.20% and a negative net margin of 7.31%. The business had revenue of $85.60 million during the quarter, compared to analysts’ expectations of $88.29 million. During the same period in the previous year, the firm posted $0.15 earnings per share. The company’s revenue was down 2.1% on a year-over-year basis.

Several research analysts have recently issued reports on ANGO shares. Canaccord Genuity restated a “hold” rating and set a $17.50 price objective on shares of AngioDynamics in a report on Monday, February 27th. Zacks Investment Research downgraded shares of AngioDynamics from a “hold” rating to a “sell” rating in a report on Friday, March 10th. Cantor Fitzgerald restated a “buy” rating and set a $20.00 price objective on shares of AngioDynamics in a report on Thursday, March 30th. Finally, Craig Hallum set a $20.00 price objective on shares of AngioDynamics and gave the stock a “buy” rating in a report on Saturday, April 1st. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $18.58.

COPYRIGHT VIOLATION WARNING: This news story was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.tickerreport.com/banking-finance/2655864/zacks-brokerages-anticipate-angiodynamics-inc-ango-to-announce-0-16-eps.html.

Shares of AngioDynamics (NASDAQ ANGO) traded down 0.829% during midday trading on Thursday, hitting $16.145. The stock had a trading volume of 67,630 shares. The stock’s market cap is $593.81 million. AngioDynamics has a 12-month low of $12.25 and a 12-month high of $18.18. The stock has a 50-day moving average price of $15.63 and a 200-day moving average price of $16.34.

In related news, major shareholder Avista Capital Partners Gp, Ll sold 2,350,000 shares of the company’s stock in a transaction dated Wednesday, April 12th. The shares were sold at an average price of $16.00, for a total value of $37,600,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 1.88% of the company’s stock.

A number of hedge funds have recently bought and sold shares of the stock. Teachers Retirement System of The State of Kentucky boosted its stake in AngioDynamics by 77.5% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 7,100 shares of the medical instruments supplier’s stock worth $123,000 after buying an additional 3,100 shares during the last quarter. Municipal Employees Retirement System of Michigan boosted its stake in AngioDynamics by 3.0% in the first quarter. Municipal Employees Retirement System of Michigan now owns 7,200 shares of the medical instruments supplier’s stock worth $125,000 after buying an additional 210 shares during the last quarter. Mason Street Advisors LLC boosted its stake in AngioDynamics by 8.5% in the first quarter. Mason Street Advisors LLC now owns 7,470 shares of the medical instruments supplier’s stock worth $130,000 after buying an additional 584 shares during the last quarter. Acrospire Investment Management LLC acquired a new stake in AngioDynamics during the first quarter worth $149,000. Finally, Old Mutual Global Investors UK Ltd. acquired a new stake in AngioDynamics during the first quarter worth $164,000. 84.20% of the stock is currently owned by institutional investors and hedge funds.

About AngioDynamics

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:ANGO”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Get a free copy of the Zacks research report on AngioDynamics (ANGO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for AngioDynamics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
President Trump Hurting Tourism in the U.S.
President Trump Hurting Tourism in the U.S.
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Blue Apron Filed Thursday for Public Offering
Blue Apron Filed Thursday for Public Offering
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Large Auto Lender Checked Just 8% of Incomes for Applicants
Large Auto Lender Checked Just 8% of Incomes for Applicants


Leave a Reply

© 2006-2017 Ticker Report. Google+.